Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder.

atrial fibrillation atrial flutter embolic stroke of undetermined source ischemic stroke loop recorder

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2024
Historique:
received: 13 01 2024
accepted: 21 02 2024
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: epublish

Résumé

Covert atrial fibrillation (AF) is a predominant aetiology of embolic stroke of undetermined source (ESUS). Evidence suggested that AF is more frequently detected by implantable loop recorder (ILR) than by conventional monitoring. However, the predictive factors associated with occult AF detected using ILRs are not well established yet. In this study we aim to investigate the predictors of AF detection in patients with ESUS undergoing an ILR. This observational multi-centre study included consecutive ESUS patients who underwent ILR implantation. The infarcts were divided in deep, cortical infarcts or both. The infarction sites were categorized as anterior and middle cerebral artery, posterior cerebral artery with and without brainstem/cerebellum involvement. Multivariable logistic regression analysis was performed to investigate variables associated with AF detection. Overall, 3,000 patients were initially identified. However, in total, 127 patients who consecutively underwent ILR implantation were included in our analysis. AF was detected in 33 (26%) out of 127 patients. The median follow-up was 411 days. There were no significant differences in clinical characteristics and comorbidities between patients with and without AF detected. AF was detected more often after posterior cerebral artery infarct with brainstem/cerebellum involvement ( Our study showed that posterior circulation infarcts with brainstem/cerebellum involvement are associated with AF detection in ESUS patients undergoing ILR. Larger prospective studies are needed to validate our findings.

Sections du résumé

Background UNASSIGNED
Covert atrial fibrillation (AF) is a predominant aetiology of embolic stroke of undetermined source (ESUS). Evidence suggested that AF is more frequently detected by implantable loop recorder (ILR) than by conventional monitoring. However, the predictive factors associated with occult AF detected using ILRs are not well established yet. In this study we aim to investigate the predictors of AF detection in patients with ESUS undergoing an ILR.
Methods UNASSIGNED
This observational multi-centre study included consecutive ESUS patients who underwent ILR implantation. The infarcts were divided in deep, cortical infarcts or both. The infarction sites were categorized as anterior and middle cerebral artery, posterior cerebral artery with and without brainstem/cerebellum involvement. Multivariable logistic regression analysis was performed to investigate variables associated with AF detection.
Results UNASSIGNED
Overall, 3,000 patients were initially identified. However, in total, 127 patients who consecutively underwent ILR implantation were included in our analysis. AF was detected in 33 (26%) out of 127 patients. The median follow-up was 411 days. There were no significant differences in clinical characteristics and comorbidities between patients with and without AF detected. AF was detected more often after posterior cerebral artery infarct with brainstem/cerebellum involvement (
Conclusion UNASSIGNED
Our study showed that posterior circulation infarcts with brainstem/cerebellum involvement are associated with AF detection in ESUS patients undergoing ILR. Larger prospective studies are needed to validate our findings.

Identifiants

pubmed: 38500754
doi: 10.3389/fcvm.2024.1369914
pmc: PMC10944994
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1369914

Informations de copyright

© 2024 D'Anna, La Cava, Khetarpal, Karjikar, Almohtadi, Romoli, Foschi, Ornello, De Santis, Sacco, Abu-Rumeileh, Lorenzut, Pavoni, Valente, Merlino, Almeida, Barnard, Guan, Banerjee and Lim.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Lucio D'Anna (L)

Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom.
Department of Brain Sciences, Imperial College London, London, United Kingdom.

Roberta La Cava (R)

Department of Brain Sciences, Imperial College London, London, United Kingdom.

Ashni Khetarpal (A)

Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom.

Abeer Karjikar (A)

Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom.

Ahmad Almohtadi (A)

Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom.

Michele Romoli (M)

Neurology and Stroke Unit, Department of Neuroscience, Bufalini Hospital, AUSL Romagna, Cesena, Italy.

Matteo Foschi (M)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Raffaele Ornello (R)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Federico De Santis (F)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Simona Sacco (S)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Samir Abu-Rumeileh (S)

Department of Neurology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Simone Lorenzut (S)

Stroke Unit, Udine University Hospital, Udine, Italy.

Daisy Pavoni (D)

Cardiothoracic Department, Udine University Hospital, Udine, Italy.

Mariarosaria Valente (M)

Clinical Neurology, Udine University Hospital and DAME, University of Udine, Udine, Italy.

Giovanni Merlino (G)

Stroke Unit and Clinical Neurology, Udine University Hospital, Udine, Italy.

Soraia Almeida (S)

Department of Cardiology, Hammersmith Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom.

Asha Barnard (A)

Department of Cardiology, Hammersmith Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom.

Jianqun Guan (J)

Department of Cardiology, Hammersmith Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom.

Soma Banerjee (S)

Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom.
Department of Brain Sciences, Imperial College London, London, United Kingdom.

Phang Boon Lim (PB)

Department of Cardiology, Hammersmith Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom.

Classifications MeSH